138 related articles for article (PubMed ID: 38740744)
1. FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development.
Ji J; Qian Q; Cheng W; Ye X; Jing A; Ma S; Ding Y; Ma X; Wang Y; Sun Q; Wang X; Chen Y; Zhu L; Yuan Q; Xu M; Qin J; Ma L; Yang J; Zhang M; Geng T; Wang S; Wang D; Song Y; Zhang B; Xu Y; Xu L; Liu S; Liu W; Liu B
Cell Death Dis; 2024 May; 15(5):332. PubMed ID: 38740744
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Small-Molecule Inhibitors of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer.
Ganier L; Betzi S; Derviaux C; Roche P; Dessaux C; Muller C; Hoffer L; Morelli X; Borg JP
ACS Chem Biol; 2022 May; 17(5):1061-1072. PubMed ID: 35483008
[TBL] [Abstract][Full Text] [Related]
3. Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7.
Yu B; Wu K; Wang X; Zhang J; Wang L; Jiang Y; Zhu X; Chen W; Yan M
Cell Death Dis; 2018 Oct; 9(11):1082. PubMed ID: 30348980
[TBL] [Abstract][Full Text] [Related]
4. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
5. Ptk7 promotes non-canonical Wnt/PCP-mediated morphogenesis and inhibits Wnt/β-catenin-dependent cell fate decisions during vertebrate development.
Hayes M; Naito M; Daulat A; Angers S; Ciruna B
Development; 2013 Apr; 140(8):1807-18. PubMed ID: 23533179
[TBL] [Abstract][Full Text] [Related]
6. PTK7 localization and protein stability is affected by canonical Wnt ligands.
Berger H; Breuer M; Peradziryi H; Podleschny M; Jacob R; Borchers A
J Cell Sci; 2017 Jun; 130(11):1890-1903. PubMed ID: 28420671
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin.
Wang Y; Cao J; Liu W; Zhang J; Wang Z; Zhang Y; Hou L; Chen S; Hao P; Zhang L; Zhuang M; Yu Y; Li D; Fan G
J Biol Chem; 2019 Nov; 294(48):18306-18323. PubMed ID: 31653698
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3.
Basu M; Roy SS
J Biol Chem; 2013 Feb; 288(6):4355-67. PubMed ID: 23250740
[TBL] [Abstract][Full Text] [Related]
9. FOXP4 promotes laryngeal squamous cell carcinoma progression through directly targeting LEF‑1.
Shi J; Wang J; Cheng H; Liu S; Hao X; Lan L; Wu G; Liu M; Zhao Y
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34590150
[TBL] [Abstract][Full Text] [Related]
10. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.
Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K
Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518
[TBL] [Abstract][Full Text] [Related]
11. FOXP4-AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer.
Hua T; Tian YJ; Wang RM; Zhao CF; Kong YH; Tian RQ; Wang W; Ma LX
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33870423
[TBL] [Abstract][Full Text] [Related]
12. Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p.
Zhou Y; Jin Z; Wang C
Biomed Pharmacother; 2019 Dec; 120():109449. PubMed ID: 31627092
[TBL] [Abstract][Full Text] [Related]
13. FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.
Asad M; Wong MK; Tan TZ; Choolani M; Low J; Mori S; Virshup D; Thiery JP; Huang RY
Cell Death Dis; 2014 Jul; 5(7):e1346. PubMed ID: 25032869
[TBL] [Abstract][Full Text] [Related]
14. FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogen-activated protein kinase (MAPK) signaling pathway.
Basu M; Mukhopadhyay S; Chatterjee U; Roy SS
J Biol Chem; 2014 Jan; 289(3):1415-28. PubMed ID: 24253043
[TBL] [Abstract][Full Text] [Related]
15. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.
Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z
Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212
[TBL] [Abstract][Full Text] [Related]
16. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
Zhang C; Zhang Z; Zhang S; Wang W; Hu P
Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer.
Li J; Yang S; Su N; Wang Y; Yu J; Qiu H; He X
Tumour Biol; 2016 Feb; 37(2):2057-65. PubMed ID: 26341496
[TBL] [Abstract][Full Text] [Related]
18. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
[TBL] [Abstract][Full Text] [Related]
20. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
